| http://www.w3.org/ns/prov#value | - However, typical dosage forms of the invention comprise a compound of any one of formulas (I) through (III), or Table 1, or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof in an amount of from about 1 mg to about 1000 mg, preferably in an amount of from about 50 mg to about 500 mg, and most preferably in an amount of from about 75 mg to about 350 mg.
|
